IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
32.89
-1.07 (-3.15%)
At close: Oct 29, 2026, 4:00 PM EDT
33.01
+0.12 (0.36%)
After-hours: Oct 29, 2026, 7:11 PM EDT
IDEAYA Biosciences Market Cap
IDEAYA Biosciences has a market cap or net worth of $3.17 billion as of October 29, 2026. It is the 4,919th most valuable company in the world and the 1,486th biggest in the United States. Its market cap has increased by 9.10% in one year.
Market Cap
3.17B
Enterprise Value
1.96B
1-Year Change
9.10%
Global Rank
Country Rank
#1,486 United States
Category
ChartMarket Cap Chart
Since May 23, 2019, IDEAYA Biosciences's market cap has increased from $215.57M to $3.17B, an increase of 1,372.18%. That is a compound annual growth rate of 43.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 3.17B | 4.72% |
| Dec 31, 2025 | 3.03B | 36.44% |
| Dec 31, 2024 | 2.22B | -3.15% |
| Dec 29, 2023 | 2.29B | 162.34% |
| Dec 30, 2022 | 874.22M | -3.92% |
| Dec 31, 2021 | 909.90M | 123.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xenon Pharmaceuticals | 3.52B |
| Acadia Pharmaceuticals | 3.50B |
| Parabilis Medicines | 3.48B |
| Celcuity | 3.40B |
| Enliven Therapeutics | 3.28B |
| Telix Pharmaceuticals | 3.22B |
| Dyne Therapeutics | 3.17B |
| Tarsus Pharmaceuticals | 3.16B |